Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;261(11):3223-3229.
doi: 10.1007/s00417-023-06138-6. Epub 2023 Jun 17.

Pre-operative versus post-operative intravitreal aflibercept injection for management of DME in patients undergoing cataract surgery

Abeer M Khattab  1   2 , Sherein M Hagras  3 , Nancy M Lotfy  4
Affiliations

Pre-operative versus post-operative intravitreal aflibercept injection for management of DME in patients undergoing cataract surgery

Abeer M Khattab et al. Graefes Arch Clin Exp Ophthalmol. 2023 Nov.

Abstract

Aim: The aim of this paper is to investigate the need of deferring cataract surgery until treating the co-existing diabetic macular edema (DME) using intravitreal (IVI) anti-vascular endothelial growth factor (anti-VEGF).

Methods: A prospective randomized interventional study included diabetic patients with visually significant cataract and DME. Patients were divided into 2 groups. Group A received three preoperative intravitreal (IVI) aflibercept injections with a monthly interval; the third injection was given intra-operatively. Group B received a single intra-operative injection, and two post-operative injections with a monthly interval. The primary outcome measure was the change in central macular thickness (CMT) at 1st and 6th month post-operative. The secondary outcome measures were best corrected visual acuity (BCVA) at same points and any documented adverse effects.

Results: Forty patients were enrolled in the study, 20 patients in each group. Means of CMT at 1 month post-operatively were significantly higher in group B than group A but no statistical difference at 6 months. There was no statistical difference between the 2 groups regarding BCVA at 1 or 6 months post-operatively. Compared with the baseline values, BCVA and CMT improved significantly after 1 and 6 months within both groups.

Conclusion: IVI of aflibercept given before cataract surgeries does not seem to have superior effect over postoperative injections in either macular thickness or visual outcomes. Hence, preoperative controlling of DME might not be mandatory in patients undergoing cataract surgery.

Clinical trial registration: The study is registered in clinical trial. Gov (NCT05731089).

Keywords: Aflibercept; Cataract; Diabetic macular edema; Diabetic retinopathy.

PubMed Disclaimer

References

    1. Kim SJ, Equi R, Bressler NM (2007) Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114(5):881–889 - DOI - PubMed
    1. Meyer CH (2007) Current treatment approaches in diabetic macular edema. Ophthalmologica 221(2):118–131 - DOI - PubMed
    1. Patel JI, Hykin PG, Cree IA (2006) Diabetic cataract removal: postoperative progression of maculopathy–growth factor and clinical analysis. Br J Ophthalmol 90(6):697–701 - DOI - PubMed - PMC
    1. Boscia F, Giancipoli E, D’Amico Ricci G, Pinna A (2017) Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol 28(1):23–28 - DOI - PubMed
    1. Steinle NC, Lampen SIR, Wykoff CC (2018) The intersection of diabetes mellitus and cataract surgery: current state of management. Ophthalmol Retina 2(2):83–85 - DOI - PubMed

Associated data

LinkOut - more resources